Site Search

... and Ensuring Access to New Tests & Treatments Virtual Event - September 29, 2020 11:00 AM - 12:00 PM Cancer remains a critical public health problem and how new cures are developed and delivered will continue to change.  Getting new and affordable cancer therapies from the ... will include: Drug Development:  Advancements in medical research have unleashed new and improved therapies that are revolutionizing cancer care.  What is the process for transforming this research into new drugs and therapies?  What are the challenges in getting new treatments to the ...

WASHINGTON, D.C. November 18, 2015 Patients with health coverage bought through one of the marketplaces created under the Affordable Care Act (ACA) continue to face challenges finding out which cancer drugs are covered by their plan and at what cost, according to a new analysis ... information is imperative for cancer patients, survivors and their loved ones as they work to make informed decisions about the best health coverage for them and their families, said Chris Hansen, president of ACS CAN, the advocacy affiliate of the American Cancer Society. Cancer ...

... process that could lead to a shortage of a particular drug.ξ It also establishes an FDA task force to work with the Secretary of Health and Human Services to create a strategic plan that promotes interagency coordination in an effort to avert or mitigate drug shortages. The ... The proposal was intended to curb abuse by illegal users of the drugs, but it would have had the unintended consequence of creating barriers to care for many patients and survivors who are often prescribed these medications to complete their disease-directed treatments, sleep through the ... of the medication. Additionally, the bill recognizes the value that patients bring to the drug review process, requiring the Secretary of Health and Human Services to implement strategies that will allow the FDA staff to better identify patients eligible to participate in appropriate ...

... drug shortage crisis continues to have a significant impact on cancer patients. One in every 10 cancer patients and survivors report impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (59%), according to a recent survey ... there are 16 oncology drugs listed in the shortage , a number of which don’t have an effective alternative and have led to worse health outcomes for cancer patients.   The full text of the letter can be read here.   0 American Cancer Society Cancer Action Network Issues ...